← Back to Search

Bone Graft Extender

MagnetOs Putty for Degenerative Disc Disease (PARTNER Trial)

N/A
Waitlist Available
Research Sponsored by Kuros Biosurgery AG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 2, week 6, month 3, 6, and 12
Awards & highlights
No Placebo-Only Group

Summary

This trial is being done to assess the safety and effectiveness of MagnetOs Putty when used in this specific way.

Eligible Conditions
  • Spinal Fusion
  • Degenerative Disc Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 2, week 6, month 3, 6, and 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 2, week 6, month 3, 6, and 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Radiographic Fusion by CT Scan
Secondary study objectives
Functional Outcome by Oswestry Disability Index
Back
Interbody lumbar fusion assessed by plain radiographs
+4 more
Other study objectives
Health Economic - Duration of Hospitalization
Health Economic - Duration of Surgery
Health Economic - Quality of Life
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: MagnetOs PuttyExperimental Treatment1 Intervention
MagnetOs Putty use in instrumented posterolateral fusion, 7cc-10cc mixed with autograft bone in a 1:1 ratio per spine level at the randomized assigned side.
Group II: Local autograftExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MagnetOs Putty
2021
N/A
~30

Find a Location

Who is running the clinical trial?

Kuros Biosurgery AGLead Sponsor
10 Previous Clinical Trials
881 Total Patients Enrolled
Orthopaedic Institute of Western KentuckyUNKNOWN
Simplified Clinical Data Systems, LLCIndustry Sponsor
6 Previous Clinical Trials
274 Total Patients Enrolled
Pascal Longlade, MDStudy DirectorKuros BioSciences B.V.
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top